Cargando…

A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer

Diabetes is directly related to the risk of breast cancer (BC) occurrence and worsened BC prognosis. Currently, there are no specific treatments for diabetes‐associated BC. This paper aims to understand the fundamental mechanisms of diabetes‐induced BC progression and to develop personalized treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Qiongyu, Huang, Zhimin, Li, Qun, Liu, Dingxie, Wang, Piwen, Wang, Kun, Li, Jieqing, Cao, Wei, Deng, Wenhong, Wu, Ke, Su, Rui, Liu, Zhongmin, Vadgama, Jay, Wu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867195/ https://www.ncbi.nlm.nih.gov/pubmed/35023320 http://dx.doi.org/10.1002/advs.202102303

Ejemplares similares

ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
por: Liu, Dingxie, et al.
Publicado: (2022)

Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA
por: Hao, Qiongyu, et al.
Publicado: (2020)

Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies
por: Hao, Qiongyu, et al.
Publicado: (2022)

CCL2/CCR2 signaling in cancer pathogenesis
por: Hao, Qiongyu, et al.
Publicado: (2020)

Tumor-Derived Exosomes in Tumor-Induced Immune Suppression
por: Hao, Qiongyu, et al.
Publicado: (2022)

Celecoxib in breast cancer prevention and therapy
por: Li, Jieqing, et al.
Publicado: (2018)

AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
por: Cao, Wei, et al.
Publicado: (2019)

Wild-Type TP53 Predicts Poor Prognosis in Patients with Gastric Cancer
por: Deng, Wenhong, et al.
Publicado: (2021)

PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer
por: Li, Qun, et al.
Publicado: (2019)

Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis
por: Liu, Dingxie, et al.
Publicado: (2021)

Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor
por: Hao, Qiongyu, et al.
Publicado: (2020)

Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer
por: Shum, Hang Chee Erin, et al.
Publicado: (2023)

Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells
por: Chung, Seyung S., et al.
Publicado: (2018)

Association of an anaplastic lymphoma kinase pathway signature with cell de‐differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer
por: Liu, Dingxie, et al.
Publicado: (2020)

Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
por: Wang, Piwen, et al.
Publicado: (2016)

Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer
por: Zhang, Zongjing, et al.
Publicado: (2014)

Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy
por: Zhang, Leqiang, et al.
Publicado: (2022)

Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells
por: Tian, Shiliu, et al.
Publicado: (2022)

MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A
por: Liu, Kun, et al.
Publicado: (2018)

Evaluation of myocardial viability in patients with acute myocardial infarction: Layer-specific analysis of 2-dimensional speckle tracking echocardiography
por: Liu, Kun, et al.
Publicado: (2019)

Transcriptional defects and reprogramming barriers in somatic cell nuclear reprogramming as revealed by single-embryo RNA sequencing
por: Liu, Yong, et al.
Publicado: (2018)

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
por: Dong, Yan, et al.
Publicado: (2021)

Infrared and visible image fusion via octave Gaussian pyramid framework
por: Yan, Lei, et al.
Publicado: (2021)

Reprogramming efficiency and pluripotency of mule iPSCs over its parents
por: Zhang, Jia, et al.
Publicado: (2023)

High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming
por: Huang, Lijun, et al.
Publicado: (2021)

Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma
por: Zhou, Xinke, et al.
Publicado: (2015)

p18 inhibits reprogramming through inactivation of Cdk4/6
por: Zhu, Shaohua, et al.
Publicado: (2016)

A two-step lineage reprogramming strategy to generate functionally competent human hepatocytes from fibroblasts
por: Xie, Bingqing, et al.
Publicado: (2019)

Exploring the Mechanisms of Differentiation, Dedifferentiation, Reprogramming and Transdifferentiation
por: Xu, Li, et al.
Publicado: (2014)

Coexpression analysis identifies nuclear reprogramming barriers of somatic cell nuclear transfer embryos
por: Zuo, Yongchun, et al.
Publicado: (2017)

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control
por: Chen, Jian, et al.
Publicado: (2023)

REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer
por: Liu, Dingxie, et al.
Publicado: (2015)

Small‐molecule‐driven direct reprogramming of Müller cells into bipolar‐like cells
por: Yang, Pan, et al.
Publicado: (2022)

A Wrinkling and Etching-Assisted Regrowth Strategy for Large-Area Bilayer Graphene Preparation on Cu
por: Li, Qiongyu, et al.
Publicado: (2023)

Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming
por: Yamaguchi, Shinpei, et al.
Publicado: (2013)

Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
por: Cui, Meng-Ying, et al.
Publicado: (2022)

Total coumarins of Pileostegia tomentella induces cell death in SCLC by reprogramming metabolic patterns, possibly through attenuating β-catenin/AMPK/SIRT1
por: Liu, Ying, et al.
Publicado: (2023)

Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
por: Wang, Piwen, et al.
Publicado: (2010)

Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer: The function of lipid metabolism reprogramming in pancreatic cancer
por: Guo, Duancheng, et al.
Publicado: (2023)

How to reprogram human fibroblasts to neurons
por: Xu, Ziran, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v2i3onbnknobh1ea4lljinfl00